Antidote Stocking at Hospitals in North Palestine



References:

ζ)>ιfme JvaniafvfJfeaftfi          Зпегкеа


1. Yang CC, Wu JF, Ong HC, Hung SC, Kuo
YP, Sa CH, Chen SS, Deng JF. Taiwan
National Poison Center: Epidemiologic
data 1985-1993. J Toxicol Clin Toxicol.
J
Toxicol Clin Toxicol.
1996;34(6):651-63

2. Mannaioni PF. Pattern of acute intoxica-
tion in Florence: A comparative investi-
gation.
Intensive Care Med.
1991;17:S24-S31.

3. Dart RC, Stark Y, Fulton B, Koziol-Mclain
J, Lowenstein SR Insufficient stocking of
poison antidotes in hospital pharma-
cies.
JAMA. 1996;276:1508-1510.

4. Litovitz TL, Felberg L, White S, Klein-
Schwartz W. 1995 Annual report of the
American Association of Poison Control
Centers toxic exposure surveillance sys-
tem.
Am J Emerg Med. 1996;14(5):487-
537.

5. Pronczuk de Garbino J, Haines JA, Jacob-
sen D, Meredith T. Evaluation of anti-
dotes: Activities of the international
programme on chemical safety.
J Toxi-
col Clin Toxicol.
1997;35(4):333-343.

6. Woolf AD, Chrisanthus K. On-site avail-
ability of selected antidotes: results of a
survey of Massachusetts hospitals.
Am J
Emerg Med.
1997;15(1):62-66.

7. Howland MA, Weisman R, Sauter D,
Goldfrank L. Nonavailability of poison
antidotes [letter].
N Engl J Med.
1986;314(14):927-928.

8. Chyka PA, Connor HG. Availability of an-
tidotes in rural and urban hospitals in
Tennessee.
Am J Hosp Pharm
1994;51(10):1346-1348.

9. Teresi WM, King WD. Survey of the
stocking of poison antidotes in Alabama
hospitals.
South Med J. 1999;92
(12):1151-1156.

10. Juurlink DN, McGuigan MA, Paton TW,
Redelmeier DA. Availability of antidotes
in acute care hospitals in Ontario.
CMAJ.
2001;165(1):27-30.

11. Bailey B, Bussieres JF. Antidote avail-
ability in Quebec hospital pharmacies:
impact of
N-acetylcysteine and nalox-
one consumption.
Can J Clin Pharmacol.
2000;7(4):198-204.

12. Solheim L, Andrew E, Jacobsen D. Anti-
dote availability in Norway.
Tidsskr Nor
Laegeforen.
2002;122(11):1111-1113.

13. Hruby K. Availability of antidotes in hos-
pital pharmacies in the Czech Republic.
Ceska Slov Farm. 2003;52(5):231-240.

14. Hara C, Hashizume T, Tanaka J et al.
Problems in hospital preparation of
acute poisoning antagonist (methylene
blue injection)
Chudoku Kenkyu.
2006;19(3):257-263.

15. Dart RC, Goldfrank LR, Chyka PA, Lotzer
D, Woolf AD, McNally J, et al. Combined
evidence-based literature analysis and
consensus guidelines for stocking of
emergency antidotes in the United
States.
Ann Emerg Med.
2000;36(2):126-132.

16. Guideline on antidote availability for ac-
cident and emergency department:
Guy’s and St Thomas’ poison unit, Roy-
al College of surgeons of England,
British association for emergency
medicine.
       http://www.emergen-

cymed.org.uk

17. The WHO Expert Committee The use of
essential drugs. Model List of Essential
Drugs (ninth list). Seventh report of the
WHO Expert Committee.
Geneva, World
Health Organization, 1997 (WHO Tech-
nical Report Series, No. 867).

18. Goldfrank LR, Flomenbaum NE, Lewin
NA, Weisman RS, Howland MA, Hoffman
RS, editors. Goldfrank's toxicologic
emergencies. 8th ed. New York,NY. Mc-
Graw-Hill; 2006.

19. Betten DP, Vohra RB, Cook MD, Mat-
teucci MJ, Clark RF. Antidote use in the
critically ill poisoned patient.
J Intensive
Care Med.
2006;21(5):255-277.

20. Bowden CA, Krenzelok EP. Clinical Appli-
cations of commonly used contempo-
rary antidotes: A US perspective.
Drug
Safety
1997;16(1):9-47.

21. Hall AH, Kulig KW, Rumack BH. Drug-
and                 chemical-induced

methaemoglobinemia: Clinical features
and management.
Med Toxicol
1986;1(4):253-260.

22. Tafuri J. Roberts J. Organophosphate
poisoning. Ann Emerg Med 1987;
16(2):193-202.

23. Sivilotti MLA, Eisen JS, Lee JS, Peterson
RG. Can emergency departments not
afford to carry essential antidotes?
CJEM 2002;4(1):23-33.

24. Burda AM. Poison antidotes: issues of
inadequate stocking with review of uses
of 24 common antidotal agents.
J
Pharm Prac
1997;10(4):235-248.

25. Kanatani, M S, Kearney, T S, Levin, R H
et al., Treatment of toxicologic emer-
gencies - antidote preparedness [ab-
stract].
Vet Hum Toxicol 1992;34:319.

26. Parker DP, Dart RC, McNally JT. Critical
deficiencies in the treatment of toxico-
logic emergencies: Antidote stocking in
Arizona hospitals [abstract].
Vet Hum
Toxicol
1990;32:376

OJHAS Vol 5 Issue 4(4) - Sawalha AF, Sweileh WM, Zyoud SH, Al-Jabi SW. Antidote Stocking at Hospitals in North Palestine




More intriguing information

1. A COMPARATIVE STUDY OF ALTERNATIVE ECONOMETRIC PACKAGES: AN APPLICATION TO ITALIAN DEPOSIT INTEREST RATES
2. Trade and Empire, 1700-1870
3. On the Desirability of Taxing Charitable Contributions
4. New Evidence on the Puzzles. Results from Agnostic Identification on Monetary Policy and Exchange Rates.
5. The name is absent
6. The name is absent
7. The name is absent
8. GROWTH, UNEMPLOYMENT AND THE WAGE SETTING PROCESS.
9. Momentum in Australian Stock Returns: An Update
10. Testing Gribat´s Law Across Regions. Evidence from Spain.
11. Partner Selection Criteria in Strategic Alliances When to Ally with Weak Partners
12. Investment and Interest Rate Policy in the Open Economy
13. The Advantage of Cooperatives under Asymmetric Cost Information
14. The name is absent
15. The name is absent
16. Short Term Memory May Be the Depletion of the Readily Releasable Pool of Presynaptic Neurotransmitter Vesicles
17. The name is absent
18. Smith and Rawls Share a Room
19. Innovation and business performance - a provisional multi-regional analysis
20. Emissions Trading, Electricity Industry Restructuring and Investment in Pollution Abatement